Crkl, a 39-kD SH2, SH3 domain-containing adapter protein, is constitutively
tyrosine phosphorylated in hematopoietic cells from chronic myelogenous le
ukemia (CML) patients. We recently reported that thrombopoietin induces tyr
osine phosphorylation of Crkl in normal platelets. In this study, we demons
trate that thrombopoietin induces association of Crkl with a tyrosine phosp
horylated 95- to 100-kD protein in platelets and in UT7/TPO cells, a thromb
opoietin-dependent megakaryocytic cell line. With specific antibodies again
st STATE, we demonstrate that the 95- to 100-kD protein in Crkl immunopreci
pitates is STAT5. This coimmunoprecipitation was specific in that Crkl immu
noprecipitates do not contain STATE, although STATE becomes tyrosine phosph
orylated in thrombopoietin-stimulated platelets. The coimmunoprecipitaion o
f Crkl with STATE was inhibited by the immunizing peptide for Crkl antisera
or phenyl phosphate (20 mmol/L). After denaturing of Crkl immunoprecipitat
es, Crkl was still immunoprecipitated by Crkl antisera. However, coimmunopr
ecipitation of STATE was not observed. Coincident with STATE tyrosine phosp
horylation, thrombopoietin induces activation of STATE DNA-binding activity
as demonstrated by electrophoretic mobility shift assays (EMSA). Using a p
-casein promoter STAT5 binding site as a probe, we have also demonstrated t
hat Crkl antisera supershift the STAT5-DNA complex, suggesting that Crkl is
a component of the complex in the nucleus. Furthermore, interleukin-3 (IL-
3), granulocyte-macrophage colony-stimulating factor (GMCSF), and erythropo
ietin also induce Crkl-STAT5 complex formation in responding cells in a sti
mulation-dependent manner. In vitro, glutathione S-transferase (GST)-Crkl b
ound to STATE inducibly through its SH2 domain. These results indicate that
thrombopoietin, IL-3, GM-CSF, and erythropoietin commonly induce associati
on of STAT5 and Crkl and that the complex translocates to the nucleus and b
inds to DNA. Interestingly, such association between STAT5 and Crkl was not
observed in cytokine-stimulated murine cells, suggesting an intriguing pos
sibility that components of the human STAT5-DNA complex may be different fr
om those of the murine counterpart. (C) 1998 by The American Society of Hem
atology.